Notifications | Sex | Age group (years) | Crude incidence (100,000 per year) 2012–2022 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | (%) | Male (%) | Female (%) | < 5 (%) | 5–19 (%) | 20–39 (%) | 40–59 (%) | ≥ 60 (%) | Mean | Range | |
All notifications | 14,087,045 | 100 | 45 | 50 | 5 | 19 | 37 | 24 | 15 | 5013 | 994–39,089 |
Disease group | |||||||||||
Gastrointestinal | 566,595 | 4 | 52 | 48 | 18.4 | 15.1 | 26.5 | 19.2 | 20.8 | 209 | 154–254 |
Respiratory | 11,641,375 | 82.6 | 44 | 50 | 5.6 | 20.1 | 33.1 | 25.2 | 15.9 | 4108 | 202–38,141 |
Sexually transmissible | 1,358,281 | 9.6 | 53 | 47 | 0.1 | 16.1 | 70.9 | 11.4 | 1.5 | 503 | 441–594 |
Bloodborne viral hepatitis | 171,842 | 1.2 | 62 | 38 | 0.2 | 2.5 | 47.4 | 38.1 | 11.8 | 64 | 47–76 |
Vector-borne | 80,654 | 0.6 | 48 | 52 | 0.3 | 6.1 | 32.9 | 40.5 | 20.2 | 30 | 14–51 |
Other | 268,298 | 1.9 | 46 | 54 | 1.1 | 9.1 | 23.8 | 28 | 38 | 99 | 63–125 |
Imported | 23,622 | 0.2 | 55 | 45 | 3.3 | 13.4 | 42.7 | 30.1 | 10.5 | 9 | 0–13 |
Jurisdiction | |||||||||||
Australian Capital Territory | 286,695 | 2 | 47 | 50 | 5.4 | 18.6 | 39.3 | 24 | 12.7 | 5947 | 912–51,953 |
New South Wales | 4,794,516 | 341 | 49 | 51 | 5.4 | 19.7 | 35.8 | 24.1 | 15 | 5359 | 685–43,234 |
Northern Territory | 198,091 | 1.4 | 47 | 53 | 7.4 | 20.7 | 42.3 | 20.9 | 8.7 | 7279 | 2735–45,904 |
Queensland | 1,986,999 | 14.1 | 45 | 52 | 5.6 | 16.9 | 37.5 | 23.1 | 16.4 | 3521 | 1222–21,173 |
South Australia | 1,194,180 | 8.5 | 47 | 52 | 6.1 | 19.6 | 33.1 | 23.5 | 17.4 | 6098 | 1071–49,643 |
Tasmania | 202,936 | 1.4 | 45 | 54 | 5.4 | 16.1 | 33.7 | 23.2 | 21.6 | 3567 | 803–26,296 |
Victoria | 3,743,878 | 26.6 | 47 | 52 | 5.1 | 18.3 | 37.6 | 23.9 | 14.8 | 5222 | 955–41,678 |
Western Australia | 1,679,750 | 11.9 | 30 | 33 | 5.3 | 20.6 | 35.9 | 24.7 | 13 | 5642 | 1053–48,128 |